This study aims to validate the efficacy and safety of subthreshold laser photocoagulation on high-risk macular drusen in early age-related macular degeneration which has a high risk of conversion to exudative AMD.
SAVE Study (Stop Early Age-related Macular Degeneration form Vision Loss Eternally)
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Enrollment
21
Selective Subthreshold Laser Photocoagulation is applied to the periphery of high-risk macular drusen
To prevent choroidal neovascularization, intravitreal Anti-VEGF injection is done on a 3 month interval up to 1 year.
Seoul National University Bundang Hospital
Seongnam, Gyunggi-do, South Korea
Change in drusen size
Time frame: 3 month interval
Best Corrected Visual Acuity (BCVA)
ETDRS and Snellen visual acuity measurement
Time frame: 3 months interval
Change in drusen distribution
Time frame: 3 month interval
Change in autofluorescence
Time frame: 3 month interval
Choroidal Neovascularization
Time frame: 3 months interval
Contrast Sensitivity
Contrast Sensitivity Test
Time frame: 3 months interval
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.